Your browser doesn't support javascript.
loading
Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States.
Brogan, Anita J; Davis, Ashley E; Goodwin, Bridgett.
Affiliation
  • Brogan AJ; RTI Health Solutions, Research Triangle Park, NC, United States of America.
  • Davis AE; RTI Health Solutions, Research Triangle Park, NC, United States of America.
  • Goodwin B; Merck & Co., Inc., Kenilworth, NJ, United States of America.
PLoS One ; 13(8): e0203293, 2018.
Article in En | MEDLINE | ID: mdl-30161205
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials / Health_economic_evaluation Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials / Health_economic_evaluation Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: United States